Critical Path Innovation Meeting (CPIM) Topics Held to Date

Critical Path Innovation Meeting TopicCritical Path Innovation Meeting Date
Use of MRI of Joints as Potential Clinical Trial Endpoints in Patients with Rheumatoid Arthritis
June 2013
Use of Hyperpolarized Noble Gas MRI to Measure Lung Function in Patients with Cystic Fibrosis
July 2013
Use of Bone Scan Assessment as a Potential Clinical Trial Endpoint or for Qualification as a Biomarker
July 2013
Use of in vitro Testing to Predict Drug Sensitization Potential
October 2013
Potential Approaches in Drug Development for Adrenomyeloneuropathy
December 2013
Issues in the Laboratory Measurement of Dystrophin
July 2014
Bile Salt Export Pump Inhibition as a Biomarker
May 2015
Use of Disease Progression Modeling for Amyotrophic Lateral Sclerosis
June 2015
Use of a Database of Clinical Trial Data
August 2015
Use of a Database of Genomic and Clinical Data
September 2015
Patient Reported Outcome Assessment for Primary Sclerosing Cholangitis
October 2015
Drug Development for Mitochondrial Diseases
October 2015
Use of Circulating Tumor Biomarkers
October 2015
Patient Reported Outcome Assessment for early stage breast cancer
October 2015
Using Genetic Data to Advance Drug Development
January 2016
A Novel Analytic Method for Pharmacokinetic Data Interpretation
January 2016
A Diagnostic Tool to Advance Cancer Drug Development
January 2016
Approaches to Developing Therapies for Patients with Severely Debilitating and Life Threatening Conditions
February 2016
Biomarkers for Traumatic Brain Injury Clinical Trials
March 2016
Use of a Placebo Response Tool in Clinical StudiesApril 2016
Digital Pathology Software SystemApril 2016
Mucolipidosis Type IV Translational ResearchMay 2016
Natural History Studies in Primary Sclerosing CholangitisJune 2016
Development of Release Active ProductsJuly 2016
Multi-System Assessment of Postnatal Development Following Extremely Preterm BirthJuly 2016
Pediatric Cholestatic Liver Disease EndpointsJuly 2016
Disease Interception Therapy in Rheumatoid ArthritisJuly 2016
Symptom Measurement in Hepatocellular CarcinomaJuly 2016
Targeting Shared Molecular Etiologies Underlying Multiple Rare Diseases (SaME)July 2016
Natural History Studies in Angelman SyndromeJuly 2016
Update on the Pediatric Trials ConsortiumAugust 2016
Development of a Genomic DatabaseSeptember 2016
Disease Interception Therapy in Type 1 DiabetesOctober 2016
Atopic Dermatitis in Pediatric PatientsOctober 2016
Disease Interception Strategy in Cataracts and PresbyopiaOctober 2016
Registry for Pediatric Inflammatory Bowel DiseaseNovember 2016
C1M Assessments in Rheumatoid ArthritisNovember 2016
Tool to Evaluate Duplicates in Clinical TrialsDecember 2016
Raman Spectroscopy to Analyze Compounded DrugsDecember 2016
Biomarkers to Identify Drug Induced Pancreatic InjuryJanuary 2017
A Tool to Assess Clinical Trial Site Performance and Data QualityJanuary 2017
The Role of Inflammation and Immune Response in DuchenneJanuary 2017
Approaches to Advance Regulatory Science TrainingFebruary 2017
Novel Drug Development Tools and Biomarkers to Support Tuberculosis Drug RegimenMarch 2017
Development of Innovative Novel ExcipientsMarch 2017
Use of Biomarkers to Enrich for Cardiac Events in Cardiovascular Clinical TrialsMarch 2017
Use of Virtual Reality Platform in Clinical TrialsMarch 2017
Development of a Patient Reported Outcome Instrument for Alopecia AreataApril 2017
Pediatric Microdosing Research Using Accelerator Mass Spectrometry (AMS)May 2017
Challenges Related to Drug Development for Cerebral Cavernous Malformations (CMM) Patient CommunityMay 2017
Health Related Quality of Life Assessment in DiabetesJune 2017
Physical Activity Accelermetry Assessment for Analgesic Clinical Trials (PAACT)June 2017
Outcome Measures for Type 1 DiabetesJuly 2017
3D Bioprinted Human Tissue ModelsAugust 2017
Outcome Measures for Type 1 DiabetesAugust 2017
Chronic Obstructive Pulmonary Disease (COPD) Assessment TestAugust 2017
The Use of Wearable Devices to Collect Endpoint Data in Clinical TrialsSeptember 2017
Outcome Assessments in Acute PancreatitisOctober 2017
Bring Your Own Device PRO AssessmentsOctober 2017
Adrenomyeloneuropathy (AMN)October 2017
Drug Development Tools for Charcot-Marie Tooth DiseaseNovember 2017
Genetic Prion DiseaseNovember 2017
Clinical Assessment Tools for Alopecia AreataDecember 2017
Disease Severity Score for Influenza and other Acute Respiratory VirusesJanuary 2018
Translational Pharmaceutics based drug development in the USFebruary 2018
Development of Prophylactic Treatments for Asthma and Other Allergic DiseasesMarch 2018
Hutchinson-Gilford Progeria Syndrome Biomarker DevelopmentApril 2018
Biomarkers and Clinical Outcome Assessments for Fragile X SyndromeApril 2018
A Patient-Centric Approach to Long-term Follow-up StudiesMay 2018
Clinical Outcome Assessment tools for Batten DiseaseJuly 2018
Universal networking technology to promote innovative business models to improve patient care
October 2018


Page Last Updated: 03/06/2019
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English